enVVeno Medical Corporation NVNO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.72M | -18.82M | -19.47M | -21.97M | -23.07M |
| Total Depreciation and Amortization | 390.00K | 491.00K | 489.00K | 494.00K | 503.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.38M | 3.48M | 3.81M | 4.23M | 4.50M |
| Change in Net Operating Assets | -1.66M | 59.00K | -396.00K | 10.00K | 950.00K |
| Cash from Operations | -14.62M | -14.79M | -15.57M | -17.23M | -17.11M |
| Capital Expenditure | 0.00 | -5.00K | -5.00K | -9.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 14.27M | 13.43M | 15.86M | 627.00K | 3.21M |
| Cash from Investing | 14.27M | 13.43M | 15.86M | 618.00K | 3.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.15M | 1.02M | 1.02M | 241.00K | 13.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.15M | 1.02M | 1.02M | 241.00K | 13.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 797.00K | -340.00K | 1.31M | -16.37M | -336.00K |